- The evidence suggests that cognitive assessment tools that are completed by people themselves could be used in the detection and diagnosis of dementia. - There is not enough evidence to recommend ...

Agreement Reached on Primary Endpoint and Phase 3 Trial Design. Oral APX3330 is a Late-Stage Clinical Asset Available for Partnering. FARMINGTON HILLS, Mich., Dec. 19, 2024 (GLOBE ...

In 2024, the federal government continued to shape the research compliance landscape with significant developments for research institutions ...